financetom
Business
financetom
/
Business
/
Twitter cracks down on COVID vaccine misinformation
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Twitter cracks down on COVID vaccine misinformation
Mar 1, 2021 10:24 PM

Twitter says it has begun labeling tweets that include misleading information about COVID-19 vaccines and using a strike system to eventually remove accounts that repeatedly violate its rules. The company said Monday that it has started using human reviewers to assess whether tweets violate its policy against COVID vaccine misinformation. Eventually, the work will be done by a combination of humans and automation, it said.

Twitter had already banned some COVID-related misinformation in December, including falsehoods about how the virus spreads, whether masks are effective and the risk of infection and death.

Through the use of the strike system, we hope to educate people on why certain content breaks our rules so they have the opportunity to further consider their behavior and their impact on the public conversation, Twitter said in a blog post-Monday.

People with one violation or strike will see no action. Two strikes will lead to an account being locked for 12 hours. Two strikes will lead to an account being locked for 12 hours.

Facebook has also stepped up its vaccine misinformation fight after years of half-hearted enforcement. It announced an expanded policy last month that includes all vaccines not just those against COVID-19.

Also Read

: Now, talk about anything: Twitter India introduces voice messaging feature

San Francisco-based Twitter did not immediately respond to a message seeking comment on whether it also plans to include broader anti-vax misinformation in its policies.

First Published:Mar 2, 2021 7:24 AM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Terns Pharmaceuticals Launching Share Offering
Terns Pharmaceuticals Launching Share Offering
Sep 10, 2024
04:45 PM EDT, 09/09/2024 (MT Newswires) -- Terns Pharmaceuticals ( TERN ) said Monday it has started a proposed underwritten public offering of $125 million of shares and pre-funded warrants to buy shares. The company said it expects to give its underwriters, including Jefferies and TD Cowen, a 30-day option to buy up to an additional $18.75 million of shares....
Mission Produce Fiscal Q3 Adjusted Earnings, Sales Rise -- Shares Soar After Hours
Mission Produce Fiscal Q3 Adjusted Earnings, Sales Rise -- Shares Soar After Hours
Sep 10, 2024
04:38 PM EDT, 09/09/2024 (MT Newswires) -- Mission Produce ( AVO ) reported fiscal Q3 adjusted net income late Monday of $0.23 per diluted share, up from $0.15 a year earlier. Two analysts surveyed by Capital IQ expected EPS of $0.03 normalized. Sales for the quarter ended July 31 were $324 million, compared with $261.4 million a year earlier. Two...
Rubrik Q2 Loss Narrows, Revenue Up; Issues Guidance
Rubrik Q2 Loss Narrows, Revenue Up; Issues Guidance
Sep 10, 2024
04:26 PM EDT, 09/09/2024 (MT Newswires) -- Rubrik ( RBRK ) late Monday reported a Q2 non-GAAP net loss of $0.40 per diluted share, compared with a $1.33 loss a year ago. Analysts polled by Capital IQ expected a $0.49 loss. Revenue for the quarter ended July 31 was $204.95 million, compared with $151.54 million a year earlier. Analysts expected...
Limoneira Fiscal Q3 Adjusted Earnings, Revenue Rise -- Shares Up After Hours
Limoneira Fiscal Q3 Adjusted Earnings, Revenue Rise -- Shares Up After Hours
Sep 10, 2024
04:41 PM EDT, 09/09/2024 (MT Newswires) -- Limoneira ( LMNR ) reported late Monday fiscal Q3 adjusted net income of $0.42 per diluted share, up from $0.02 a year earlier. Two analysts polled by Capital IQ expected $0.34. Revenue for the quarter ended July 31 also climbed to $63.3 million from $52.5 million a year earlier. Three analysts expected $63.6...
Copyright 2023-2026 - www.financetom.com All Rights Reserved